VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $817,000 | -20.2% | 51,324 | +4.2% | 0.39% | -19.3% |
| Q4 2017 | $1,024,000 | +39.5% | 49,255 | -3.8% | 0.49% | +38.1% |
| Q3 2017 | $734,000 | -23.6% | 51,188 | -7.8% | 0.35% | -25.6% |
| Q2 2017 | $961,000 | +64.8% | 55,543 | +5.0% | 0.47% | +57.1% |
| Q1 2017 | $583,000 | +23.8% | 52,896 | +63.0% | 0.30% | +11.1% |
| Q4 2016 | $471,000 | +20.2% | 32,449 | +103.4% | 0.27% | +16.8% |
| Q3 2016 | $392,000 | +94.1% | 15,954 | +58.7% | 0.23% | +90.2% |
| Q2 2016 | $202,000 | – | 10,053 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |